Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JZP047 SAD and Food Effect Study in Healthy Participants
NCT07377539Phase 1Active, not recruiting
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Feb 2026
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of JZP047 (3 arms), sponsored by Jazz Pharmaceuticals plc. Primary endpoints: Number of Participants Reporting Treatment-emergent Adverse Events at Day 90, Number of Participants Who Discontinued The Study at Day 90 and 8 more. Started Feb 2026; status: active, not recruiting.
02
Drugs
JZP047
Beyond the preview
Go deeper on NCT07377539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07377539.